Related Experiment Video
Updated: May 8, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
[RILPIVIRINE -- a novel HIV-1 non-nucleoside reverse transcriptase inhibitor]
Svatava Snopková1, Kateřina Havlíčková, Pavel Polák
1Department of Infectious Diseases, Medical faculty of Masaryk University, The University Hospital Brno, Czech Republic. svatava.snopkova@fnbrno.cz
Klinicka Mikrobiologie a Infekcni Lekarstvi
|August 16, 2013
Summary
Rilpivirine (RPV) is a second-generation non-nucleoside reverse transcriptase inhibitor for HIV-1. Its unique structure provides a high resistance barrier, making it a key option in current HIV/AIDS treatment regimens.
Area of Science:
- Pharmacology and Virology
- Drug Metabolism and Interactions
Context:
- Review of rilpivirine (RPV), an orally administered second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI).
- Focus on RPV for antiretroviral-naive patients diagnosed with HIV-1 infection.
- Examination of RPV within the context of current HIV/AIDS treatment guidelines and therapeutic regimens.
Purpose:
- To summarize the pharmacokinetic profile, metabolism, and drug interactions of rilpivirine (RPV).
- To highlight the unique structural features of RPV, specifically its conformational flexibility and adaptability, contributing to a high resistance barrier.
- To review multicentre studies (ECHO and THRIVE) and discuss the role of RPV in contemporary HIV/AIDS management.
Summary:
- Rilpivirine (RPV) exhibits favorable pharmacokinetic properties, distinct metabolic pathways, and clinically relevant drug interactions.
- The diarylpyrimidine (DAPY) structure of RPV confers significant conformational flexibility, leading to a high genetic barrier to resistance.
- Clinical trial data from ECHO and THRIVE support the efficacy and safety of RPV in treatment-naive individuals.
Impact:
- Provides essential information for clinicians managing HIV-1 infection with rilpivirine.
- Contributes to understanding the mechanisms behind the high resistance barrier of second-generation NNRTIs.
- Informs the optimal use of RPV within evolving HIV/AIDS therapeutic strategies.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...